JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matot, I.
Right arrow Articles by Jurim, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matot, I.
Right arrow Articles by Jurim, O.
Related Collections
Right arrow Obstetrics
Right arrow Pharmacology
Anesth Analg 2001;92:590-595
© 2001 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

The Protective Effect of Acadesine on Lung Ischemia-Reperfusion Injury

Idit Matot, MD*, and Oded Jurim, MD{dagger}

*Department of Anesthesiology and CCM and the Laboratory of Experimental Surgery; and the {dagger}Department of Surgery, Hadassah University Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel

Address correspondence and reprint requests to Idit Matot, MD, Department of Anesthesiology and Critical Care Medicine, Hadassah Hebrew University Medical Center, PO Box 12000, Jerusalem 91120, Israel. Address e-mail to matoth{at}cc.huji.ac.il

The purine precursor acadesine is highly effective in preventing ischemia-reperfusion (I-R) injury of the heart and intestine. The aim of this study was to test the effect of acadesine on I-R–induced lung injury. The lobar artery of the left lower lung lobe in intact-chest, spontaneously breathing cats was occluded for 2 h (Group 1, ischemia) and reperfused for 3 h (Group 2, I-R). Animals were subjected to one of the following three protocols: acadesine administered IV 15 min before ischemia (Group 3), 15 min before reperfusion (Group 4), or 30 min after reperfusion (Group 5). Acadesine was administered at an initial dose of 2.5 mg · kg-1 · min-1 for 5 min, followed by 0.5 mg · kg-1 · min-1 until the end of reperfusion. Injury was assessed by histologic examination. The right lower lobe served as control. Compared with the right lower lobe, which showed no abnormal findings in any group (percentage of injured alveoli, 2% ± 1% to 4% ± 2%), the left lower lung lobe in the I-R group revealed a disrupted alveolar structure with 63% ± 9% injured alveoli. Ischemia alone did not produce alterations in alveolar structure. Acadesine significantly reduced the number of injured alveoli when given before ischemia (4% ± 1%) or reperfusion (6% ± 2%) but not when administered after reperfusion (62% ± 8%). In conclusion, acadesine, when administered before ischemia or reperfusion, can blunt I-R–induced lung injury. The mechanism underlying the protection remains to be elucidated.

Implications: Acadesine reduces ischemia-reperfusion–induced lung injury in spontaneously breathing cats when administered before ischemia or reperfusion, but not after reperfusion.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.